Back to Squamous Cell Carcinoma of Rectum

Squamous Cell Carcinoma of Rectum — Clinical Trials

MONDO:00185153 active·2 recruitingLast updated: Mar 16, 2026, 11:17 AM

Trial Landscape

Squamous Cell Carcinoma of Rectum has an emerging clinical trial program, driven by drug treatment and biological therapy.

Recruiting

Active Trials

By Approach

Drug Treatment3

Biological Therapy3

Procedure1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

Phase 2

Sponsor Types

Academic/Other2NIH1Industry1

Top Sponsors

TScan Therapeutics, Inc.

Trial Locations

United States3 trials

China1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

4 Trials

Phase 2Recruiting

NCT04929028

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Aug 2022Est. completion: Sep 2031Updated: Mar 2026

Phase 2Recruiting

NCT05686226

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Sponsor:Christian Hinrichs

United StatesStarted: Mar 2023Est. completion: Jan 2027Updated: Feb 2026

Phase 1Active, Not Recruiting

NCT05973487

A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors

Sponsor:TScan Therapeutics, Inc.

United StatesStarted: May 2024Est. completion: Dec 2026Updated: Nov 2025

Stay informed about clinical trials for Squamous Cell Carcinoma of Rectum.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 11:17 AM